Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade
Clinical trial NCT05265962 · UNKNOWN
Trial details
- NCT number
- NCT05265962
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-12-31
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.